Skip to content

Aliaxin SV - Superior Volume (Standard)

by Rose Pharma S.A.

Ref Aliaxin SV - Superior Volume (Standard)

Active European Union

CE MDR CE MDD

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberB-07640187920550 Basic UDI-DI 07640187920550UDI-DIDate18 Sep 2026RegisteredStatusActive
European UnionCE/MDD NumberB-07640187920550 Basic UDI-DI 07640187920550UDI-DIDate18 Sep 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

Italy
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR, CE/MDD Active

  • Italy

Specification

EUDAMED

Device Name
Aliaxin/Nuavis
Model / Reference
Aliaxin SV - Superior Volume (Standard)
Primary DI / UDI-DI
07640187920550
Basic UDI-DI
B-07640187920550, 764018792ANCLHAER
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
EU market of registration
Italy
Medical Purpose
ALIAXIN/NUAVIS

Manufacturer details

EUDAMED SRN
CH-MF-000033472
Authorised representative
ROSE PHARMA ITALIA S.R.L. IT-AR-000021266

Other devices from Rose Pharma S.A.

See all devices from Rose Pharma S.A. →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No